Topical dsRNA challenges may induce overexpression of airway antiviral cytokines in symptomatic allergic disease. A pilot in vivo study in nasal airways.

Summary, in English

Airway challenge with dsRNA is of interest since this agent acts on TLR3 and mimics rhinoviral (RV) infection-induced interferons/cytokines. Contrasting frequent employment of dsRNA in epithelial cell cultures there is no information on effects of dsRNA administered to human airways in vivo. Here we explore effects of nasal dsRNA challenges in subjects with seasonal allergic rhinitis inside and outside Swedish birch pollen season.

• Author: Angelica Brandelius; Morgan Andersson; Lena Uller
• Department/s: Respiratory Immunopharmacology; Otorhinolaryngology (Lund)
• Publishing year: 2014
• Language: English
• Pages: 1816-1819
• Publication/Series: Respiratory Medicine
• Volume: 108
• Issue: 12
• Links: http://www.ncbi.nlm.nih.gov/pubmed/25456711?dopt=Abstract; http://dx.doi.org/10.1016/j.rmed.2014.10.010
• Document type: Journal article
• Publisher: Elsevier
• Topic: Respiratory Medicine and Allergy
• Status: Published
• Research group: Respiratory Immunopharmacology
• ISBN/ISSN/Other: ISSN: 1532-3064